共 9 条
- [6] A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing FRONTIERS IN IMMUNOLOGY, 2022, 13
- [7] Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies JOURNAL OF DERMATOLOGY, 2023, 50 (08): : 1058 - 1062
- [9] Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2803 - 2808